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Abstract Protein phosphatase 2CK (PP2CK) or PP2CL-1
expressed in COS7 cells suppressed anisomycin- and NaCl-
enhanced phosphorylations of p38 co-expressed in the cells.
PP2CK or PP2CL-1 expression also suppressed both basal and
stress-enhanced phosphorylations of MKK3b and MKK6b, which
are upstream protein kinases of p38, and of MKK4, which is one
of the major upstream protein kinases of JNK. Basal activity of
MKK7, another upstream protein kinase of JNK, was also
suppressed by PP2CK or PP2CL-1 expression. However, basal
as well as serum-activated phosphorylation of MKK1a, an
upstream protein kinase of ERKs, was not affected by PP2CL or
PP2CL-1. A catalytically inactive mutant of PP2CL-1 further
enhanced the NaCl-stimulated phosphorylations of MMK3b,
MKK4 and MKK6b, suggesting that this mutant PP2CL-1
works as a dominant negative form. These results suggest that
PP2C selectively inhibits the SAPK pathways through suppres-
sion of MKK3b, MKK4, MKK6b and MKK7 activities in
mammalian cells.
z 1998 Federation of European Biochemical Societies.
Key words: Protein phosphatase 2C;
Stress-activated protein kinase signal pathway
1. Introduction
Stress-activated kinases (SAPKs) constitute a subfamily of
the mitogen-activated protein (MAP) kinase superfamily [1],
and c-Jun N-terminal kinases (JNK1, 2 and 3) and p38
SAPKs (p38 K, L, Q and N) have been reported to be present
in mammalian cells [1^7]. Cell biological studies have revealed
that these SAPKs are activated by extracellular stress, includ-
ing osmotic shock, heat shock, oxidative stress, protein syn-
thesis inhibitors, ultraviolet irradiation and anti-cancer drugs
[1]. SAPKs have also been reported to be activated by some
cytokines [1]. During the course of activation, these SAPKs
are phosphorylated at the conserved tyrosine and threonine
residues in the catalytic domain by dual-speci¢c protein kin-
ases called MAP kinase kinases (MKKs; MKK3, MKK4,
MKK6 and MKK7) [1,8^11]. Substrate speci¢city studies re-
vealed that MKK3 and MKK6 are responsible for phospho-
rylation and activation of p38 SAPKs and that MKK4 and
MKK7 are the major protein kinases phosphorylating JNKs
[1^11]. These MKKs are also phosphorylated at their con-
served serine and threonine residues in response to extracel-
lular stress. Recently, several MKK kinases (MKKKs) that
activate MKKs have been identi¢ed, including MEKK1,
MEKK2, MEKK3, MEKK4, the mixed lineage kinase
(MLK) family, TGF L-activated kinase 1 (TAK1), apoptosis
signal-regulating kinase 1 (ASK1) and MAP three kinase 1
(MTK1) [1,9,12^24].
The SAPKs are highly conserved among eukaryotes. In the
budding yeast Saccharomyces cerevisiae, the Hog1p (SAPK)
pathway is activated by hyperosmotic shock [25,26]. In the
¢ssion yeast Schizosaccharomyces pombe, the Spc1 (SAPK)
pathway is activated by heat shock, oxidative stress, nutrient
stress and osmotic shock [25,27], and the resulting activated
Spc1 induces the expression of various genes through the ac-
tivation of Atf1 transcription factor [25].
Molecular genetic studies have indicated that yeast SAPK
pathways are negatively regulated by protein phosphatase 2C
[PP2C, one of the four major protein serine/threonine phos-
phatases (PP1, 2A, 2B and 2C)] [25]. The target of PP2C
(PTC1 and PTC3 of S. cerevisiae and Ptc1 and Ptc3 of S.
pombe) in the SAPK system was ¢rst predicted to be SAPK
(Hog1) itself or a component upstream of SAPK in S. cere-
visiae cells. However, a recent study showed that the target of
Ptc1 in S. pombe cells lies downstream of SAPK (Spc1) [28].
Studies on the functions of mammalian PP2C have sug-
gested that PP2C is involved in the regulation of AMP-acti-
vated protein kinase [29] and Ca2/calmodulin-dependent pro-
tein kinase II [30], but whether it also participates in the
regulation of SAPK systems in mammalian cells is unknown.
In this study we have addressed this question using transient
expression of recombinant proteins in COS7 cells and provide
evidence indicating that PP2C selectively suppresses the
SAPK signal pathways in COS7 cells.
2. Materials and methods
2.1. Materials
The restriction enzymes and other modifying enzymes used for
DNA manipulation were from Takara (Kyoto, Japan). Anti-6UHis
and anti-HA antibodies were obtained from Santa Cruz (Santa Cruz,
CA, USA). Anti-phospho-p38, anti-phospho-JNK, anti-phospho-
ERK1/2, anti-phospho-MKK4 and anti-phospho-MKK3/6 antibodies
were from New England Biolabs (Beverly, MA, USA). Anti-Flag
(M2) antibody was purchased from IBI Kodak (New Haven, CT,
USA). Anisomycin was purchased from Sigma (St. Louis, MO,
USA), anti-mouse IgG-alkaline phosphatase conjugate was from
Promega (Madison, WI, USA) and all other reagents used were
from Wako Pure Chemical (Osaka, Japan).
2.2. Expression plasmids
The HA-PP2CK and HA-PP2CL-1 cDNAs [31] were subcloned into
pcDNA3 (Invitrogen, Netherlands) and the resultant plasmids were
named pcDNA3-HA-PP2CK and pcDNA3-HA-PP2CL-1, respec-
tively. Point mutants of PP2CL-1, which have no protein phosphatase
activity, were prepared as described elsewhere [32]. HA tag was in-
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serted into the amino-terminal end of each point mutant of PP2CL-1
by overlap polymerase chain reaction (PCR). The cDNAs encoding
HA-tagged PP2CL-1 point mutants were subcloned into pcDNA3. Dr.
Jiahuai Han (The Scripps Research Institute) provided pcDNA3-Flag-
p38, pcDNA3-MKK3b and pcDNA3-MKK6b [8]. MKK1a cDNA
was purchased from American Type Culture Collection. ERK1
cDNA was from Dr. Jacques Pouyssegur (UniversiteŁ de Nice).
JNK1 cDNA was from Dr. Michael Karin (University of California
at San Diego, CA, USA). MKK4 and MKK7 cDNAs were prepared
using PCR. All the cDNAs were subcloned into expression vector
pcDNA3 (Invitrogen, Netherlands), and epitope tags were added by
synthesized oligonucleotides. The plasmid pGEX-2T-glutathione S-
transferase (GST)-ATF2 (1^96) was a gift from Dr. Roger J. Davis
(University of Massachusetts) [33] and pGEX-2T-GST-c-Jun was pro-
vided by Dr. Masahiko Hibi (Osaka University) [2].
2.3. Cell culture and transfection
COS7 cells were grown in Dulbecco’s minimum Eagle’s medium
(Gibco BRL, Rockville, USA) supplemented with 10% (v/v) fetal
calf serum (FCS) and transfected by the DEAE-dextran method [34]
or using lipofectamine (Gibco BRL).
2.4. Immune complex kinase assay
The COS7 cells were lysed in bu¡er A (20 mM HEPES, pH 7.4, 1%
(v/v) Triton X-100, 137 mM NaCl, 1 mM EDTA, 1 mM sodium
orthovanadate, 50 mM NaF, 1 mM dithiothreitol and 1 mM phenyl-
methylsulfonyl £uoride) and aliquots of the lysates (100 Wg protein)
were subjected to the immune complex kinase assays, as described
previously [8], using GST-activating transcription factor 2 (ATF2)
(for p38 activity assay), GST-c-Jun (for JNK activity assay) and
MBP (for ERK activity assay) as the substrates. The radioactivities
incorporated into the substrates were determined using BAS 2000
image analyzer (Fuji, Japan).
2.5. Western blot analysis
Western blot analysis was performed by the standard procedure,
using the anti-HA, anti-phospho-p38, anti-Flag, anti-6UHis, anti-
phospho-MKK3/6, anti-phospho-MKK4 and anti-phospho MKK1
antibodies. The chemiluminescence of each blot was detected with
enhanced chemiluminescence (Amersham, Buckinghamshire, UK).
2.6. Protein phosphatase activity assay
The COS7 cells were lysed in NaF-free bu¡er A and the PP2C
activities (Mg2-dependent and okadaic acid-insensitive protein phos-
phatase activities) of the cell extracts were assayed using
[32P]phosphohistone as the substrate, as described previously [35].
3. Results and discussion
3.1. PP2C suppresses stress-enhanced tyrosine phosphorylation
of p38
As p38 SAPK has been established to be the mammalian
ortholog of S. cerevisiae HOG1 [1,25,26] and S. pombe Spc1
[25,27], ¢rst, we examined whether PP2C overexpression in
COS7 cells a¡ected basal and/or stress-enhanced tyrosine
phosphorylation of p38 which was co-expressed in the cells.
When HA-tagged PP2CK was expressed transiently in COS7
cells, the PP2C activity of the cell extracts increased about
three-fold (data not shown). Then, we co-expressed Flag-
tagged p38 and HA-PP2CK in COS7 cells and determined
the tyrosine phosphorylation of Flag-p38 before and after
treating the cells with anisomycin or NaCl. The results dem-
onstrated that PP2CK suppressed basal and anisomycin- and
NaCl-enhanced tyrosine phosphorylation of p38 (Fig. 1A).
Similar results were obtained when PP2CL-1, another PP2C
isoform, was expressed in the cells instead of PP2CK. No
di¡erences in expression levels of HA-PP2CK and HA-
PP2CL-1 were observed between the untreated control and
stress inducer-treated cells. The suppression of both activity
and tyrosine phosphorylation of endogenous p38 was also
observed when HA-PP2CK or HA-PP2CL-1 alone was ex-
pressed in the COS7 cells (data not shown).
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Fig. 1. E¡ect of expression of PP2C on phosphorylation and activ-
ity of p38 and MKK3b co-expressed in COS7 cells. A: The expres-
sion plasmids of Flag-p38 and HA-PP2C were co-transfected into
COS7 cells in the ratio 1:4. The total amounts of DNA were ad-
justed with empty vector (pCDNA3). Forty-eight hours after the
transfection, the cells were treated with anisomycin (10 mg/ml, 30
min at 37‡C, lanes 4^6) or NaCl (0.7 M, 30 min at 37‡C, lanes 7^
9). The cells without treatment were used as the control (lanes 1^3).
The aliquots of the cell extracts (3 Wg protein) were immunoblotted
with anti-phospho-p38 antibody recognizing tyrosine phosphorylated
p38 (top panel), anti-Flag antibody (middle panel) and anti-HA
antibody (bottom panel). B: The expression plasmids of His-
MKK3b and HA-PP2C were co-transfected into COS7 cells in the
ratio 1:4. The cells were treated with anisomycin (lanes 4^6) or
NaCl (lanes 7^9). The cells without treatment were used as the con-
trol (lanes 1^3). Aliquots of the lysates (3^10 Wg protein) were im-
munoblotted with anti-phospho-MKK3/6 antibody (top panel), anti-
His antibody (middle panel) and anti-HA antibody (bottom panel).
(C) The expression plasmids of myc-p38, His-MKK3b and HA-
PP2C were co-transfected into COS7 cells in the ratio 1:1:2. The
cells were lysed and aliquots of the lysates (100 Wg protein) were im-
munoprecipitated with anti-myc antibody, and immune complex kin-
ase assays were performed with GST-ATF2 as the substrate. Ali-
quots of the lysates (5^10 Wg) were also immunoblotted with anti-
phospho-p38, anti-myc, anti-His and anti-HA antibodies. The re-
sults represent one of at least three reproducible experiments.
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3.2. PP2C suppresses phosphorylation and activity of MKK3
and MKK6
As PP2C is known to have high speci¢city for phosphoser-
ine and phosphothreonine residues, we speculated that the
target molecule of PP2Cs in the p38 MAPK pathway might
lie upstream of p38. Since MKK3 and MKK6 have been
found to be the major MKKs responsible for p38 activation
[1,14^16], we anticipated that phosphorylation of these
MKKs would be a¡ected by PP2C expression. In order to
verify speculation, we co-expressed HA-PP2CK or HA-
PP2CL-1 and His-MKK3b in COS7 cells and investigated
whether PP2C suppressed the phosphorylation of MKK3b
in the presence and absence of stress inducers. The phospho-
rylations of MKK3b (Fig. 1B) in the absence of stress in-
ducers were suppressed by the co-expressed PP2CK or
PP2CL-1. In parallel with the decrease in the phosphorylation
levels of MKK3b, the activity of MKK3b was reduced by the
expression of PP2CK or PP2CL-1 as determined by phospho-
rylation and activation of Myc-p38 co-expressed in the cells
(Fig. 1C). The anisomycin- or NaCl-enhanced phosphoryl-
ation of MKK3b was also suppressed by the exogenous
PP2CK and PP2CL-1 (Fig. 1B). Essentially the same results
were obtained when His-MKK6b was co-expressed with
PP2CK or PP2CL-1 in COS7 cells (Fig. 4, data not shown).
3.3. PP2C suppresses phosphorylation and/or activity of MKK4
and MKK7 but not those of MKK1
In order to determine whether PP2C has an e¡ect only on
the p38 pathway or also a¡ects the other MAP kinase path-
ways, such as ERK and JNK pathways, we tested the e¡ect of
PP2C expression on phosphorylations of MKK1 (an up-
stream protein kinase of ERK) and MKK4 (a major upstream
protein kinase of JNK).
When His-tagged MKK4 was co-expressed with PP2CK or
PP2CL-1 in COS7 cells, the basal threonine phosphorylation
of MKK4 was suppressed (Fig. 2A). In parallel with the de-
creased phosphorylation, the activity of MKK4 was sup-
pressed by PP2CK and PP2CL-1 as determined by the phos-
phorylation and activation of the co-expressed myc-JNK1
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Fig. 3. E¡ects of PP2C expression on phosphorylation and activity
of MKK1a co-expressed in COS7 cells. A: The expression plasmids
of His-MKK1a and HA-PP2C were co-transfected into COS7 cells
in the ratio 1:4. Twelve hours after the transfection, the cells were
serum starved for 36 h, then treated with 20% (v/v) FCS for 10 min
(lanes 4^6). The cells without serum treatment were used as the con-
trol (lanes 1^3). Aliquots of the lysate (5 Wg protein) were immuno-
blotted with anti-phospho-MKK1/2 antibody (top panel), anti-His
antibody (middle panel) and anti-HA antibody (bottom panel). B:
The expression plasmids of Myc-ERK1, His-MKK1a and HA-PP2C
were co-transfected into COS7 cells in the ratio 1:1:2 (lanes 3 and
4). Cells harboring the expression plasmid of myc-ERK1 alone (lane
1) or those of myc-ERK1 and His-MKK1a (lane 2) were also used.
The cells were lysed and aliquots of the lysates (100 Wg protein)
were immunoprecipitated with anti-myc antibody, and immune com-
plex kinase assays were performed with MBP as the substrate. Ali-
quots of the lysates (5^10 Wg) were immunoblotted with anti-phos-
pho-ERK1/2, anti-myc, anti-His and anti-HA antibody. The results
represent one of at least three reproducible experiments.
Fig. 2. E¡ects of PP2C on phosphorylation of MKK4 and activity
of MKK7 co-expressed in COS7 cells. A: The expression plasmids
of His-MKK4 and HA-PP2C were co-transfected into COS7 cells in
the ratio 1:4. The cells were treated with anisomycin (lanes 4^6) or
NaCl (lanes 7^9). The cells without treatment were used as the con-
trol (lanes 1^3). Aliquots of the lysates (3^10 Wg protein) were im-
munoblotted with anti-phospho-MKK4 antibody (top panel), anti-
His antibody (middle panel) and anti-HA antibody (bottom panel).
B: The expression plasmids of myc-JNK1, His-MKK7 and HA-
PP2C were co-transfected into COS7 cells in the ratio 1:1:2 (lanes
2^4). Cells transfected with the expression plasmid of myc-JNK1
alone (lane 1) or those of myc-JNK1 and His-MKK7 (lane 2) were
also used. The cells were lysed and aliquots of the lysates (100 Wg
protein) were immunoprecipitated with anti-myc antibody, and im-
mune complex kinase assays were performed with GST-c-jun as the
substrate. Aliquots of the lysates (5^10 Wg) were immunoblotted
with anti-phospho-JNK, anti-myc, anti-His and anti-HA antibodies.
The results represent one of at least three reproducible experiments.
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(data not shown). Both anisomycin and NaCl treatments of
the cells stimulated the phosphorylation of His-MKK4 and
the stress-enhanced phosphorylation of MKK4 was sup-
pressed by the expression of PP2CK or PP2CL-1 (Fig. 2A).
The activity of His-tagged MKK7 (a major upstream pro-
tein kinase of JNK) expressed in the COS7 cells was also
suppressed by the co-expression of PP2CK or PP2CL-1 as
determined by the phosphorylation and activation of myc-
JNK1 co-expressed in the cells (Fig. 2B).
Next, we co-expressed His-tagged MKK1a and HA-PP2CK
or HA-PP2CL-1 in COS7 cells and tested the e¡ect of PP2C
on the serine phosphorylation of MKK1a before and after
serum treatment of the cells. The basal phosphorylation of
His-MKK1a was a¡ected very little by co-expression of
PP2CK or PP2CL-1 (Fig. 3A). The activity of His-MKK1a
was not a¡ected by the expression of PP2CK or PP2CL-1 as
determined by phosphorylation and activation of myc-ERK1
co-expressed in the cells (Fig. 3B). Serum treatment of the
cells stimulated the phosphorylation of MKK1a, and the ex-
pression of PP2CK or PP2CL-1 did not have any in£uence on
the serum-enhanced phosphorylation of MKK1a (Fig. 3A).
Taken together, these results indicate that PP2CK and
PP2CL-1 selectively suppress the SAPK pathways (p38 and
JNK pathways) but do not a¡ect the ERK pathway.
3.4. PP2CL-1 point mutant (D243A) enhances the
phosphorylation of MKK3, MKK4 and MKK6
We have previously reported that the activities of six dis-
tinct point mutants of PP2CL-1 (D38A, D60A, H62L,
R179G, R200G and D243A) were less than 3% of that of
wild type PP2CL-1 [32]. Each of these six point mutants was
co-expressed with MKK6 in COS7 cells and the e¡ects of
these mutants on the NaCl-enhanced phosphorylation of
MKK6 were determined. Five of the six point mutants
(D38A, D60A, H62L, R179G and R200G) had little e¡ect
on the NaCl-enhanced phosphorylation of MKK6, demon-
strating that PP2CL-1 activity was required for the suppres-
sion of the phosphorylation of MKK6 (Fig. 4A). In contrast,
the expression of D243A stimulated further (60 þ 9%, mean þ
S.E.M., n = 4) the NaCl-enhanced phosphorylation of MKK6
(Fig. 4A). The stress-enhanced phosphorylations of MKK3
and MKK4 were also stimulated further by the expression
of D243A (data not shown). The stimulatory e¡ect of
D243A on MKK6 phosphorylation was also observed when
1 WM okadaic acid was present in the culture medium (Fig.
4B). Therefore, it was strongly suggested that D243A worked
as a dominant negative form of PP2CL-1 and stimulated fur-
ther the stress-enhanced phosphorylation of MKK6 by inhib-
iting the activity of endogenous PP2C, but not those of oka-
daic acid-sensitive phosphatases such as PP1 and PP2A, of
COS7 cells. The serum-stimulated phosphorylation of
MKK1a was not a¡ected by the co-expression of D243A
(data not shown). These results suggest that the endogenous
PP2C in fact participates in the selective regulation of SAPK
signalling pathways.
We have previously reported the existence of at least ¢ve
distinct isoforms of 2CL (L-1 to L-5) in mammalian cells
whose structural di¡erences are only in the 10^20 amino acids
of their carboxy-terminal regions [35]. We have recently tested
the e¡ects of expression of each of these ¢ve PP2CL isoforms
on the NaCl-enhanced phosphorylation of MKK6a co-ex-
pressed in COS7 cells and found all ¢ve isoforms suppressed
similarly the phosphorylation of MKK6a (unpublished obser-
vation). Therefore, the inhibitory e¡ect on SAPK signalling
pathways is likely to be a common feature of PP2CK and
PP2CL isoforms.
It has been reported that the expression level of Ptc1 of
¢ssion yeast cells increased following hyperosmotic shock
treatment of the cells and that the expressed Ptc1 then sup-
pressed the function of Atf1 to prevent overproduction of
glycerol [28]. We have determined using immunoblot analysis
whether the expression levels of endogenous PP2CK and
PP2CL-1 of COS7 cells were also a¡ected by hyperosmotic
stress. However, no alteration of their expression levels was
observed up to 24 h after NaCl treatment of the cells (un-
published observation). Therefore, whether the function of
PP2C is regulated by upstream signal(s) remains to be eluci-
dated.
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Fig. 4. E¡ects of expression of point mutants of PP2CL-1 on phos-
phorylation of MKK6B co-expressed in COS7 cells. A: The expres-
sion plasmids of His-MKK6b and wild type HA-PP2CL-1 or the
points mutants of PP2CL-1 (D38A, D60A, H62L, R179G, R200G
and D243A) were co-transfected into COS7 cells in the ratio 1:4.
The cells were treated with NaCl (lanes 2^9). The cells without
treatment were used as the control (lane 1). Aliquots of the lysates
(3^10 Wg protein) were immunoblotted with anti-phospho-MKK3/6
antibody (top panel), anti-His antibody (middle panel) and anti-HA
antibody (bottom panel). B: The expression plasmids of His-
MKK6b and wild type HA-PP2C of PP2CL-1(D243A) were co-
transfected into COS7 cells in the ratio 1:4. The cells were treated
with NaCl (lanes 2^5) in the presence (lanes 1, 3^6) or absence
(lane 2) of 15 WM okadaic acid. Aliquots of the lysates (3^10 Wg
protein) were immunoblotted with anti-phospho-MKK3/6 antibody
(top panel), anti-His antibody (middle panel) and anti-HA antibody
(bottom panel). The results represent one of at least three repro-
ducible experiments.
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